NCT01796041
- Conditions
- Adenocarcinoma, Breast Diseases, Breast Neoplasms, +13 more
- Locations
-
- Hospital of the University of Pennsylvania Philadelphia, Pennsylvania, United States
Clinical trial condition
Breast Neoplasms
Explore clinical trials studying Breast Neoplasms. Study availability and eligibility vary by location and protocol.
627 public trials
223 recruiting studies
Breast Neoplasms trial results
NCT02259114
- Conditions
- Breast Diseases, Breast Neoplasms, CRPC, +10 more
- Locations
-
Not specified
- Conditions
- Breast Diseases, Breast Neoplasms, Neoplasms, +5 more
- Locations
-
- Scottsdale Healthcare /ID# 120473 Scottsdale, Arizona, United States
- Mayo Clinic - Scottsdale /ID# 139932 Scottsdale, Arizona, United States
- Arizona Oncology Associates, PC-HOPE /ID# 126137 Tucson, Arizona, United States
- Usc /Id# 123310 Los Angeles, California, United States
Completed
PCA062 in pCAD-positive Tumors.
NCT02375958
- Conditions
- Breast Diseases, Breast Neoplasms, Digestive System Diseases, +14 more
- Locations
-
- Novartis Investigative Site Houston, Texas, United States
- Novartis Investigative Site San Antonio, Texas, United States
- Novartis Investigative Site Villejuif, France
- Novartis Investigative Site Milan, MI, Italy
NCT02222922
- Conditions
- Adnexal Diseases, Breast Diseases, Breast Neoplasms, +29 more
- Locations
-
- University of Alabama at Birmingham Birmingham, Alabama, United States
- University of Alabama at Birmingham Birmingham, Alabama, United States
- Scottsdale Healthcare Hospitals DBA HonorHealth Scottsdale, Arizona, United States
- University of California Davis Comprehensive Cancer Center Sacramento, California, United States
NCT01155453
- Conditions
- Advanced and Selected Solid Tumors, Breast Diseases, Breast Neoplasms, +11 more
- Locations
-
- University of California at Los Angeles Div. of Hematology/Oncology Los Angeles, California, United States
- University of Texas/MD Anderson Cancer Center Dept of MD Anderson (8) Houston, Texas, United States
- Novartis Investigative Site Leuven, Belgium
- Novartis Investigative Site Toronto, Ontario, Canada
Completed
Mirvetuximab Soravtansine as First Line in Treating Patients With Triple Negative Breast Cancer
NCT03106077
- Conditions
- Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage IIA Breast Cancer AJCC v8, Anatomic Stage IIB Breast Cancer AJCC v8, +25 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
Completed
IACS-010759 in Advanced Cancers
NCT03291938
- Conditions
- Advanced Malignant Solid Neoplasm, Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8, +46 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
Completed
Olaparib and Durvalumab in Treating Participants With Metastatic Triple Negative Breast Cancer
NCT03544125
- Conditions
- Anatomic Stage IV Breast Cancer AJCC v8, Breast Diseases, Breast Neoplasms, +10 more
- Locations
-
- OHSU Knight Cancer Institute Portland, Oregon, United States
NCT03538028
- Conditions
- Adenocarcinoma, Adenoma, Adnexal Diseases, +105 more
- Locations
-
- The Angeles Clinic and Research Center Los Angeles, California, United States
- Hackensack Medical Center Hackensack, New Jersey, United States
- Carolina BioOncology Institute Huntersville, North Carolina, United States
- Vanderbilt University Medical Center Nashville, Tennessee, United States